These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24498294)

  • 1. A recombinant rabies virus encoding two copies of the glycoprotein gene confers protection in dogs against a virulent challenge.
    Liu X; Yang Y; Sun Z; Chen J; Ai J; Dun C; Fu ZF; Niu X; Guo X
    PLoS One; 2014; 9(2):e87105. PubMed ID: 24498294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Codon optimization of G protein enhances rabies virus-induced humoral immunity.
    Pei J; Huang F; Wu Q; Luo Z; Zhang Y; Ruan J; Li Y; Zhou M; Fu Z; Zhao L
    J Gen Virol; 2019 Aug; 100(8):1222-1233. PubMed ID: 31259681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two potential recombinant rabies vaccines expressing canine parvovirus virion protein 2 induce immunogenicity to canine parvovirus and rabies virus.
    Luo J; Shi H; Tan Y; Niu X; Long T; Zhao J; Tian Q; Wang Y; Chen H; Guo X
    Vaccine; 2016 Aug; 34(37):4392-8. PubMed ID: 27449079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a recombinant rabies Flury LEP virus carrying an additional G gene creates an improved seed virus for inactivated vaccine production.
    Tao L; Ge J; Wang X; Wen Z; Zhai H; Hua T; Zhao B; Kong D; Yang C; Bu Z
    Virol J; 2011 Sep; 8():454. PubMed ID: 21943337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
    Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z
    Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective antibody response of Balb/c mice to Bali rabies virus isolate propagated in BHK-21 cells.
    Astawa INM; Agustini NLP; Masa Tenaya IW; Aryawiguna IPGW
    J Vet Med Sci; 2018 Nov; 80(10):1596-1603. PubMed ID: 30210066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of neurovirulence of flury rabies virus vaccine strains: importance of the polymerase and the glycoprotein R333Q mutation.
    Tao L; Ge J; Wang X; Zhai H; Hua T; Zhao B; Kong D; Yang C; Chen H; Bu Z
    J Virol; 2010 Sep; 84(17):8926-36. PubMed ID: 20538851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An inactivated recombinant rabies CVS-11 virus expressing two copies of the glycoprotein elicits a higher level of neutralizing antibodies and provides better protection in mice.
    Xue XH; Zheng XX; Wang HL; Ma JZ; Li L; Gai WW; Wang TC; Yang ST; Xia XZ
    Virus Genes; 2014 Jun; 48(3):411-20. PubMed ID: 24535572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs.
    Shuai L; Wang X; Wen Z; Ge J; Wang J; Zhao D; Bu Z
    Antiviral Res; 2017 Oct; 146():36-44. PubMed ID: 28822816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Host Immune Responses after Infection with Wild-Type or Lab-Attenuated Rabies Viruses in Dogs.
    Gnanadurai CW; Yang Y; Huang Y; Li Z; Leyson CM; Cooper TL; Platt SR; Harvey SB; Hooper DC; Faber M; Fu ZF
    PLoS Negl Trop Dis; 2015; 9(8):e0004023. PubMed ID: 26292099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of interleukin-6 by a recombinant rabies virus enhances its immunogenicity as a potential vaccine.
    Luo J; Zhang B; Wu Y; Tian Q; Zhao J; Lyu Z; Zhang Q; Mei M; Luo Y; Guo X
    Vaccine; 2017 Feb; 35(6):938-944. PubMed ID: 28089546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus.
    Wirblich C; Coleman CM; Kurup D; Abraham TS; Bernbaum JG; Jahrling PB; Hensley LE; Johnson RF; Frieman MB; Schnell MJ
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and characterization of P gene-deficient rabies virus.
    Shoji Y; Inoue S; Nakamichi K; Kurane I; Sakai T; Morimoto K
    Virology; 2004 Jan; 318(1):295-305. PubMed ID: 14972555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recombinant rabies virus carrying GFP between N and P affects viral transcription in vitro.
    Luo J; Zhao J; Tian Q; Mo W; Wang Y; Chen H; Guo X
    Virus Genes; 2016 Jun; 52(3):379-87. PubMed ID: 26957093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-Like Vesicles Based on Semliki Forest Virus-Containing Rabies Virus Glycoprotein Make a Safe and Efficacious Rabies Vaccine Candidate in a Mouse Model.
    Zhang C; Tian Y; Chen C; Wang Z; Pei J; Lin C; Zhou M; Fu ZF; Zhao L
    J Virol; 2021 Sep; 95(20):e0079021. PubMed ID: 34346765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AAV-expressed G protein induces robust humoral and cellular immune response and provides durable protection from rabies virus challenges in mice.
    Liu C; Li J; Yao Q; Gao Z; Cheng Y; Zhou M; Tang Y; Sun L; Dai J; Cao G; Zhang XL; Zhang R
    Vet Microbiol; 2020 Mar; 242():108578. PubMed ID: 32122589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical Development of Inactivated Rabies Virus-Based Polyvalent Vaccine Against Rabies and Filoviruses.
    Willet M; Kurup D; Papaneri A; Wirblich C; Hooper JW; Kwilas SA; Keshwara R; Hudacek A; Beilfuss S; Rudolph G; Pommerening E; Vos A; Neubert A; Jahrling P; Blaney JE; Johnson RF; Schnell MJ
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S414-24. PubMed ID: 26063224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nucleoside-modified mRNA vaccine forming rabies virus-like particle elicits strong cellular and humoral immune responses against rabies virus infection in mice.
    Liu J; Sun J; Ding X; Liu W; Wang Y; Wang Z; Peng H; Zhang Y; Su W; Jiang C
    Emerg Microbes Infect; 2024 Dec; 13(1):2389115. PubMed ID: 39129566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodies.
    Tims T; Briggs DJ; Davis RD; Moore SM; Xiang Z; Ertl HC; Fu ZF
    Vaccine; 2000 Jun; 18(25):2804-7. PubMed ID: 10812222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of replication-deficient vesicular stomatitis virus based rabies vaccine in mice.
    Park JE; Shin HJ
    Vet Q; 2021 Dec; 41(1):202-209. PubMed ID: 33985418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.